Some interesting filings and dates of filings also PR v. Deal dates.
TODOS MEDICAL LTD.
EXPLANATORY NOTE
On June 19, 2020, Todos Medical Ltd. (the “Company”) and its subsidiaries, Todos Medical USA, Inc. (“Todos Medical USA”) and Corona Diagnostics, LLC (“Corona”) entered into a Receivables Financing Agreement with Toledo Advisors, LLC (the “Lender”) for up to $25,000,000 in a revolving receivables financing facility (the “Facility”). The availability of the Facility shall terminate on the earlier of June 19, 2025 and the date on which more than $25,000,000 has been advanced. The financing is secured by all of the assets of the Company’s wholly-owned subsidiary Todos Medical USA, Inc. In addition, Todos Medical USA pledged all of the outstanding equity of Corona to the Lender. The initial draw under the Facility was on June 19, 2020 for $165,000 which is due on the earlier to occur of (i) ninety days following the date the draw was made by the Lender and (ii) the date the receivable, for which the draw was made, is paid.
On June 18, 2020, the Company entered into a distribution agreement with Meridian Health Services Network, Inc. (“Meridian”) pursuant to which the Company appointed Meridian to facilitate the distribution of the Company’s suite of COVID-19 testing solutions used for novel coronavirus for a term of two years.
This report on Form 6-K (including the exhibits hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
The PR for the Meridian deal was on June 29th
Todos Medical Enters Into Distribution Partnership With Meridian Health Services Network for COVID-19 Testing Solutions
More: https://investorshangout.com/recentnews/TOMDF#ixzz6R4iLxPF7
And today
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Todos Medical Ltd. (the “Registrant”) hereby requests the immediate withdrawal of the above-referenced registration statement, together with all exhibits and amendments thereto (the “Registration Statement”). The Registration Statement was initially filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2019.
The Registrant is requesting to withdraw the Registration Statement because it has elected not to pursue the sale of securities pursuant to the Registration Statement at this time. The Registrant confirms that no securities were sold in connection with the offering contemplated by the Registration Statement.
https://investorshangout.com/post/view?id=581...z6R4jnR4dx
TODOS MEDICAL LTD.
EXPLANATORY NOTE
On June 19, 2020, Todos Medical Ltd. (the “Company”) and its subsidiaries, Todos Medical USA, Inc. (“Todos Medical USA”) and Corona Diagnostics, LLC (“Corona”) entered into a Receivables Financing Agreement with Toledo Advisors, LLC (the “Lender”) for up to $25,000,000 in a revolving receivables financing facility (the “Facility”). The availability of the Facility shall terminate on the earlier of June 19, 2025 and the date on which more than $25,000,000 has been advanced. The financing is secured by all of the assets of the Company’s wholly-owned subsidiary Todos Medical USA, Inc. In addition, Todos Medical USA pledged all of the outstanding equity of Corona to the Lender. The initial draw under the Facility was on June 19, 2020 for $165,000 which is due on the earlier to occur of (i) ninety days following the date the draw was made by the Lender and (ii) the date the receivable, for which the draw was made, is paid.
On June 18, 2020, the Company entered into a distribution agreement with Meridian Health Services Network, Inc. (“Meridian”) pursuant to which the Company appointed Meridian to facilitate the distribution of the Company’s suite of COVID-19 testing solutions used for novel coronavirus for a term of two years.
This report on Form 6-K (including the exhibits hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
The PR for the Meridian deal was on June 29th
Todos Medical Enters Into Distribution Partnership With Meridian Health Services Network for COVID-19 Testing Solutions
More: https://investorshangout.com/recentnews/TOMDF#ixzz6R4iLxPF7
And today
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Todos Medical Ltd. (the “Registrant”) hereby requests the immediate withdrawal of the above-referenced registration statement, together with all exhibits and amendments thereto (the “Registration Statement”). The Registration Statement was initially filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2019.
The Registrant is requesting to withdraw the Registration Statement because it has elected not to pursue the sale of securities pursuant to the Registration Statement at this time. The Registrant confirms that no securities were sold in connection with the offering contemplated by the Registration Statement.
https://investorshangout.com/post/view?id=581...z6R4jnR4dx
